Approximately 65% of AIH patients present with ANAs or anti-SMA, whereas 58% of patients with type 1 AIH generate antibodies against soluble liver antigen (SLA) in the presence or absence of ANAs or anti-SMA [11]. This evidence concerns the gene SMN1 and autoimmune hepatitis.